FdaApplication
ANDA 210623
Identifiers
- fda_app_no: ANDA210623
Properties
| Property | Value |
|---|---|
| applicant_name | INGENUS PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2018-05-03 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEVOLEUCOVORIN CALCIUM | LEVOLEUCOVORIN CALCIUM | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | SOLUTION;INTRAVENOUS |
| LEVOLEUCOVORIN CALCIUM | LEVOLEUCOVORIN CALCIUM | EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | SOLUTION;INTRAVENOUS |
2 products